| Magnetic resonance Enterography findings 46 weeks after initiation of biological therapy predict long‐term adverse outcomes in Crohn's disease A Fernández‐Clotet, I Ordás, MC Masamunt, B Caballol, S Rodríguez, ... Alimentary Pharmacology & Therapeutics 59 (11), 1435-1445, 2024 | 1 | 2024 |
| Magnetic Resonance Imaging Features Indicative of Permanent Colon Damage in Ulcerative Colitis: An Exploratory Study J Rimola, J Castro-Poceiro, V Sapena, M Aduna, J Arevalo, I Vera, ... Journal of Crohn's and Colitis, jjae075, 2024 | | 2024 |
| Mo1802 BOWEL DAMAGE AND ITS ASSOCIATION WITH THE DISABILITY INDEX IN PATIENTS WITH RECENTLY DIAGNOSED CROHN'S DISEASE. J Revés, GR Madsen, JM Burisch, C Wong, N Arebi, M Dodel, A Buisson, ... Gastroenterology 166 (5), S-1117-S-1118, 2024 | | 2024 |
| 548 DISABILITY IN CROHN'S DISEASE PATIENTS AT DIAGNOSIS: FINDINGS FROM THE CROCO (CROHN'S DISEASE COHORT) STUDY J Revés, GR Madsen, JM Burisch, C Wong, N Arebi, M Dodel, A Buisson, ... Gastroenterology 166 (5), S-127, 2024 | | 2024 |
| Cyclophosphamide-free mobilisation increases safety while preserving the efficacy of autologous haematopoietic stem cell transplantation in refractory Crohn’s disease patients A Giordano, M Rovira, M Veny, R Barastegui, P Marín, C Martínez, ... Journal of Crohn's and Colitis, jjae076, 2024 | | 2024 |
| Macrophage and neutrophil heterogeneity at single-cell spatial resolution in human inflammatory bowel disease (vol 14, 4506, 2023) A Garrido-Trigo, AM Corraliza, M Veny, I Dotti, E Melon-Ardanaz, A Rill, ... NATURE COMMUNICATIONS 15 (1), 2024 | | 2024 |
| Characteristics and management of pyoderma gangrenosum and erythema nodosum in patients with inflammatory bowel disease: PIONOSO multicenter study I Rodriguez-Lago, M Vela, I Ordas, R de Francisco, MD Martin-Arranz, ... JOURNAL OF CROHNS & COLITIS 18, I1987-I1988, 2024 | | 2024 |
| Blood-derived neutrophils give rise to differentially activated populations in the mucosa of active Inflammatory Bowel Disease patients M Veny, A Sanzo-Machuca, AM Corraliza, F Strobbe, A Garrido-Trigo, ... JOURNAL OF CROHNS & COLITIS 18, I153-I154, 2024 | | 2024 |
| Differential effects of tofacitinib on macrophage activation may contribute to lack of response in ulcerative colitis patients E Melon-Ardanaz, M Veny, AM Corraliza, A Garrido-Trigo, V Gudino, ... JOURNAL OF CROHNS & COLITIS 18, I277-I278, 2024 | | 2024 |
| Author Correction: Macrophage and neutrophil heterogeneity at single-cell spatial resolution in human inflammatory bowel disease A Garrido-Trigo, AM Corraliza, M Veny, I Dotti, E Melón-Ardanaz, A Rill, ... nature communications 15, 2024 | | 2024 |
| Bowel damage and its correlation with the disability index in patients with recently diagnosed Crohn´ s Disease J Torres, G Roager Madsen, J Burisch, C Wong, N Arebi, M Bonnet-Dodel, ... European Crohn's and Colitis Organisation 2024, 2024 | | 2024 |
| Disability in Crohn’s Disease Patients at diagnosis: Findings from the CROCO (Crohn´ s Disease Cohort) study J Reves, G Roager Madsen, J Burisch, C Wong, N Arebi, M Bonnet-Dodel, ... European Crohn's and Colitis Organisation 2024, 2024 | | 2024 |
| P1115 Characteristics and management of pyoderma gangrenosum and erythema nodosum in patients with inflammatory bowel disease: PIONOSO multicenter study I Rodríguez-Lago, M Vela, I Ordás, R de Francisco, MD Martín-Arranz, ... Journal of Crohn's and Colitis 18 (Supplement_1), i2000-i2001, 2024 | | 2024 |
| P516 Subcutaneous infliximab cut-off points in a large cohort of Spanish patients with inflammatory bowel disease and factors associated with long-term outcomes M Iborra, B Caballol, A Garrido, JM Huguet, F Mesonero, A Ponferrada, ... Journal of Crohn's and Colitis 18 (Supplement_1), i1020-i1021, 2024 | | 2024 |
| P026 Differential effects of tofacitinib on macrophage activation may contribute to lack of response in ulcerative colitis patients E Melón-Ardanaz, M Veny, AM Corraliza, A Garrido-Trigo, V Gudiño, ... Journal of Crohn's and Colitis 18 (Supplement_1), i280-i281, 2024 | | 2024 |
| DOP45 Blood-derived neutrophils give rise to differentially activated populations in the mucosa of active Inflammatory Bowel Disease patients M Veny, A Sanzo-Machuca, AM Corraliza, F Strobbe, A Garrido-Trigo, ... Journal of Crohn's and Colitis 18 (Supplement_1), i154-i155, 2024 | | 2024 |
| DOP05 Bowel damage and its correlation with the disability index in patients with recently diagnosed Crohn´ s Disease J Revés, G Roager Madsen, J Burisch, C Wong, N Arebi, M Bonnet-Dodel, ... Journal of Crohn's and Colitis 18 (Supplement_1), i79-i80, 2024 | | 2024 |
| P226 Disability in Crohn’s Disease Patients at diagnosis: Findings from the CROCO (Crohn´ s Disease Cohort) study J Revés, G Roager Madsen, J Burisch, C Wong, N Arebi, M Bonnet-Dodel, ... Journal of Crohn's and Colitis 18 (Supplement_1), i563-i564, 2024 | | 2024 |
| ADC values for detecting bowel inflammation and biologic therapy response in patients with Crohn disease: a post hoc prospective trial analysis J Rimola, A Fernandez-Clotet, N Capozzi, B Caballol, S Rodríguez, ... American Journal of Roentgenology 222 (1), e2329639, 2024 | 2 | 2024 |
| De-escalating therapy in inflammatory bowel disease: Results from an observational study in clinical practice A Arenas, MJ Moreta, I Ordás, A Fernández-Clotet, B Caballol, M Gallego, ... Gastroenterologia y hepatologia, 2023 | | 2023 |
